Susceptibility-weighted imaging helps to discriminate pediatric multiple sclerosis from acute disseminated

James E Kelly1, Soe Mar2, Gina D'Angelo3

  • 1Department of Radiology, Washington University School of Medicine, St. Louis, Missouri.

Pediatric Neurology
|December 24, 2014
PubMed

Insights

Susceptibility-weighted imaging can help distinguish pediatric multiple sclerosis from acute disseminated encephalomyelitis. This MRI technique identifies more lesions in multiple sclerosis patients, aiding early diagnosis.

Area of Science:

  • Pediatric Neurology
  • Neuroimaging
  • Magnetic Resonance Imaging

Background:

  • Susceptibility-weighted imaging (SWI) is an advanced MRI technique.
  • SWI aids in detecting lesions associated with multiple sclerosis (MS) in adults.
  • Its utility in differentiating pediatric MS from acute disseminated encephalomyelitis (ADEM) is under investigation.

Purpose of the Study:

  • To evaluate the effectiveness of SWI in distinguishing between pediatric multiple sclerosis and monophasic acute disseminated encephalomyelitis.
  • To assess SWI's ability to identify specific lesion characteristics in children with central nervous system demyelination.

Main Methods:

  • Studied 18 children with acute central nervous system demyelination and recent MRI including SWI.
  • Diagnoses were confirmed using international consensus definitions.
  • Compared the number and characteristics of lesions identified on fluid-attenuated inversion recovery (FLAIR) and SWI sequences between MS and ADEM groups.

Main Results:

  • Ten children were diagnosed with MS and eight with ADEM.
  • Twenty-two percent of FLAIR lesions were detected on SWI.
  • A significantly higher percentage of FLAIR lesions were identified on SWI in the MS group (median 0.22) compared to the ADEM group (median 0.0).

Conclusions:

  • Susceptibility-weighted imaging shows promise as a tool for differentiating pediatric MS from ADEM at the time of initial presentation.
  • SWI may provide crucial imaging biomarkers for early and accurate diagnosis in pediatric demyelinating diseases.
Abstract